Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 7, 2011 - Issue
Submit an article Journal homepage
51
Views
10
CrossRef citations to date
0
Altmetric
Perspectives

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder

Maurizio Pompili1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy;2 McLean Hospital, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
,
Paola Venturini1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
,
Marco Innamorati1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
,
Gianluca Serafini1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
,
Ludovica Telesforo1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
,
David Lester3 The Richard Stockton College of New Jersey, Pomona, NJ, USA
,
Roberto Tatarelli1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
&
Paolo Girardi1 Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy
 show all
Pages 259-265 | Published online: 06 May 2011

References

  • PompiliMRihmerZInnamoratiMLesterDGirardiPTatarelliRAssessment and treatment of suicide risk in bipolar disordersExpert Rev Neurother20099110913619102673
  • VietaESanchez-MorenoJAcute and long-term treatment of maniaDialogues Clin Neurosci200810216517918689287
  • MollerHJDemyttenaereKSacchettiERushAJMontgomerySAImproving the chance of recovery from the short- and long-term consequences of depressionInt Clin Psychopharmacol200318421922512817156
  • DemyttenaereKEnzlinPDeweWCompliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairmentJ Clin Psychiatry200162Suppl 22343711599646
  • PevelerRGeorgeCKinmonthALCampbellMThompsonCEffect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trialBMJ1999319721061261510473477
  • MelfiCAChawlaAJCroghanTWHannaMPKennedySSredlKThe effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depressionArch Gen Psychiatry19985512112811329862557
  • ThaseMENierenbergAABKMPanagidesJEfficacy of mirtazapine for prevention of depressive relapse: a placebo controlled double-blind trial of recently remitted high-risk patientsJ Clin Psychiatry2001621078278811816867
  • LingamRScottJTreatment non-adherence in affective disordersActa Psychiatr Scand2002105316417211939969
  • Muller-OerlinghausenBBerghoferAAhrensBThe antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatryCan J Psychiatry200348743343912971012
  • TondoLIsacssonGBaldessariniRSuicidal behaviour in bipolar disorder: risk and preventionCNS Drugs200317749151112751919
  • CraigTJYeQBrometEJMortality among first-admission patients with psychosisCompr Psychiatry200647424625116769297
  • DuttaRBoydellJKennedyNVan OsJFearonPMurrayRMSuicide and other causes of mortality in bipolar disorder: a longitudinal studyPsychol Med200737683984717349107
  • KhalsaHMSalvatorePHennenJBaethgeCTohenMBaldessariniRJSuicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factorsJ Affect Disord20081061–217918417614135
  • MeltzerHYDritselisAYasothanUKirkpatrickPAsenapineNat Rev Drug Discov200981184384419876039
  • HussarDAAbbasCANew drugs: asenapine, iloperidone, and bepotastine besilateJ Am Pharm Assoc (2003)201050110711020097650
  • MinassianAYoungJWEvaluation of the clinical efficacy of asenapine in schizophreniaExpert Opin Pharmacother201011122107211520642375
  • CitromeLAsenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychoticInt J Clin Pract200963121762178419840150
  • McIntyreRSCohenMZhaoJAlphsLMacekTAPanagidesJA 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed statesBipolar Disord200911767368619839993
  • McIntyreRSCohenMZhaoJAlphsLMacekTAPanagidesJAsenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension studyJ Affect Disord2010126335836520537396
  • McIntyreRSCohenMZhaoJAlphsLMacekTAPanagidesJAsenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trialJ Affect Disord20101221–2273820096936
  • McIntyreRSCohenMZhaoJAlphsLMacekTAPanagidesJAsenapine versus olanzapine in acute mania: a double-blind extension studyBipolar Disord200911881582619832806
  • YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
  • McIntyreRSAsenapine: A review of acute and extension phase data in bipolar disorderCNS Neurosci Ther2010101510.1111/j.1755–5949.2010.00200x [Epub ahead of print]
  • WeberJMcCormackPLAsenapineCNS Drugs200923978179219689168

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.